Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2022 at "Primary care diabetes"
DOI: 10.1016/j.pcd.2022.03.012
Abstract: Given the CV benefit noted in the CVOTs, GLP-1RAs and SGLT-2is are given preference in T2DM guidelines. While guidelines do not report potential gender difference, those differences exist. On restricting the CVOTs results to women… read more here.
Keywords: diabetes cardiovascular; sglt women; glp 1ra; 1ra sglt ... See more keywords
Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.0115
Abstract: Type-2 diabetes mellitus (T2DM) exacerbates mechanisms of atherosclerosis and heart failure. We investigated the effects of insulin, glucagon like peptide-1 receptor agonists (GLP-1RA), sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and their combination on LV myocardial function of… read more here.
Keywords: combination; work; glp 1ra; treatment ... See more keywords